Briacell Therapeutics Corp

NASDAQ BCTX

Download Data

Briacell Therapeutics Corp Price to Sales Ratio (P/S) on June 03, 2024

Briacell Therapeutics Corp Price to Sales Ratio (P/S) is NA on June 03, 2024, a NA change year over year. The price to sales ratio compares the market price per share of a company's stock to its sales revenue per share. It is calculated by dividing the market capitalization by the revenue, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's sales revenue. A higher ratio suggests that investors are willing to pay a higher price for each unit of sales revenue, indicating positive market sentiment and expectations for future revenue growth.
  • Briacell Therapeutics Corp 52-week high Price to Sales Ratio (P/S) is NA on June 03, 2024, which is NA below the current Price to Sales Ratio (P/S).
  • Briacell Therapeutics Corp 52-week low Price to Sales Ratio (P/S) is NA on June 03, 2024, which is NA below the current Price to Sales Ratio (P/S).
  • Briacell Therapeutics Corp average Price to Sales Ratio (P/S) for the last 52 weeks is NA.
NASDAQ: BCTX

Briacell Therapeutics Corp

CEO Dr. William V. Williams M.D.
IPO Date Feb. 24, 2021
Location Canada
Headquarters Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1
Employees 16
Sector Healthcare
Industry Biotechnology
Description

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Similar companies

DAWN

Day One Biopharmaceuticals Inc

NA

NA

HEPA

Hepion Pharmaceuticals Inc

NA

NA

StockViz Staff

September 16, 2024

Any question? Send us an email